Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs?
J Inherit Metab Dis
; 29(2-3): 341-2, 2006.
Article
en En
| MEDLINE
| ID: mdl-16763897
ABSTRACT
Exposure to fibrates leads to normalization of fatty acid oxidation (FAO) in fibroblasts from patients with myopathic forms of CPT2 deficiency or VLCAD deficiency. Correction of FAO is related to a drug-induced increase of residual enzyme activity, and this could provide a new treatment strategy for these disorders.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Ácido Clofíbrico
/
PPAR gamma
/
Fibroblastos
/
Errores Innatos del Metabolismo Lipídico
/
Hipolipemiantes
Límite:
Humans
Idioma:
En
Revista:
J Inherit Metab Dis
Año:
2006
Tipo del documento:
Article
País de afiliación:
Francia